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Figure 1 - Global plasma collections. 
 Data provided by the Market Research Bureau.
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Transfusion" [Blood Transfus 2015; 13: 537-8]
Let us use all the good olive wood 
Albert Farrugia1, Corrado Del Bò2
1Department of Surgery, University of Western Australia, Perth, Australia; 2Department of Law "Cesare Beccaria", 
University of Milan, Milan, Italy 
Dear Sir,
We appreciate the importance given to our recent 
paper "Some reflections on the Code of Ethics of the 
International Society of Blood Transfusion"1 (ISBT) as 
reflected in the commissioning of Flanagan's editorial2. 
However, Flanagan asserts that our position, which 
has been carefully put together from our different 
backgrounds in transfusion (AF) and philosophy 
(CDB), arises from "Farrugia's close association 
with the commercial plasma industry"2. Flanagan's 
assertion may appear logical but is in fact, incorrect. 
It seems to be rather a case of making an observation 
on the basis of information that, since the Authors' 
profiles are clearly stated in the "Conflict of Interests" 
declaration, is irrelevant to the argument put forward. 
Other works by Farrugia are referred to in reference3 
(see references 13, 21, 48 within), which we are unable 
to cite in their entirety due to the space restrictions here. 
These clearly resonate with the concepts regarding 
voluntary non-remunerated donation (VNRD) set 
out in our paper. These papers were published during 
Farrugia's tenure as a senior public health official in 
Australia charged with the oversight of a plasma product 
supply system underpinned by a vigorously defended 
domestic monopoly, now fortunately defunct, which was 
ideologically justified by the kind of VNRD principles 
espoused by Flanagan. This led to Australia trailing 
behind other developed health systems in the adequate 
provision of essential plasma products to patients.
So much for the historical record. Like Flanagan, 
we support the concept of the Nuffield Council around 
the "Ladder of Altru sm", believing that, in human 
affairs, absolutes are rarely constructive, and we have, 
indeed, embedded within it our concept of "supplier". 
We contend that paid plasma donors make an undeniable 
contribution to the supply of sufficient safe plasma 
products globally and that this is crucial for the wellbeing 
of vulnerable patients (Figure 1). As the supply of 
plasma recovered from blood from VNRDs continues 
its inexorable decline, both through the decreased use 
of red cells resulting from Patient Blood Management 
and from the demographic imbalance between the 
donors and the users of blood, this is, if anything, 
increasing in importance. The reality is that, despite the 
best efforts of heavily subsidised blood systems such as 
those in Australia and the Netherlands where, despite 
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a praiseworthy increase in public funding, plasma 
collection continues to be a fraction that achieved by 
commercial entities, plasma supply is dependent on 
blood collection from renumerated donors. Even in 
settings in which plasma from VNRD has increased, 
this has not reduced the system's capacity to increase 
the domestically sourced supply of plasma products 
relative to the total clinical demand, while the demand 
for red blood cells, and hence VNRD sourced plasma 
collection, continues to drop (Figure 2). Excluding 
products sourced from paid donors will harm patients 
in any current landscape. 
We note and support Flanagan's concerns regarding 
donor health. We suggest that the protection of donors 
is mandatory, and includes, but is not restricted to, 
continued doubts on the collection volumes allowed by 
the US FDA on all source plasma donors, irrespective of 
payment status. We also encourage the blood collection 
sector to continue its efforts in managing the problem 
of iron deficiency in whole blood donors, especially 
women. The patient centred issues which we propose 
as the basis of all aspects of health care policy do not 
put "the health, safety and wellbeing of donors (as) 
subservient to the needs of patients" since donor health 
and safety is crucial for a safe and adequate product 
supply. Flanagan admits that incentives "should be a 
source of concern for the proponents of VNRD". We 
encourage an open and transparent debate on this issue, 
and an assessment of the reality beyond the Council of 
Europe definition espoused by proponents of VNRD. 
Are we to accept that individuals offered a choice 
between donation and incarceration are VNRD4?! We 
note that in this instance, the authority responsible for 
Figure 2 - Trends in plasma collection and product use in Australia showing levels of 
Ig consumption per 104 population, % of Ig use met by domestic plasma, use 
of red cells (RCC), and collection of plasma for fractionation (PFF). 
 A continuing increase in PFF will not be sufficient to increase the level of self-
sufficiency in Ig, while RCC use is decreasing. Data provided by the Australian 
National Blood Authority.
overseeing legislative measures preventing payment 
did not intervene. We suggest that the appropriate 
positioning of these incentives is perfectly feasible 
within the Nuffield Council's "Ladder", but that these 
may lie uneasily within the purist construct of VNRD. 
We applaud Flanagan's commitment to review the 
ISBT Code with the aim of "reflect(ing) a consensus 
view of those in the society and this will be achieved by 
internal debate and discussion." As an ISBT member 
of 30 years standing, one of us at least looks forward to 
being involved in this process. But we propose that the 
issues arising merit a wider debate, and we encourage a 
process which will "let a thousand flowers bloom" (Mao 
Tse Tung). It is now four years since the initial statements 
by Flanagan, and we caution the Society from lapsing 
into the error cited by the great Italian philosopher, 
Antonio Gramsci, who described "the master craftsman 
who was given a fine trunk of seasoned olive wood with 
which to carve a statue of Saint Peter; he carved away, 
a piece here, a piece there, shaped the wood roughly, 
modified it, corrected it - and ended up with a handle 
for a cobbler's awl"5. 
A genuine attempt towards a synthesis should give 
us, if not a statue of Saint Peter, which might be viewed 
as denominationally sectarian (although we would hope 
that the ISBT retains its status as a wider "church"), at 
least a much better monument. The Society is abundant 
in rich and seasoned olive wood, and Flanagan may 
wish to use his influence to convene a debate on this, 
possibly at a session during the coming ISBT Congress 
in Dubai. He may well conclude, as we have, that this 
would be better than singing to our respective choirs, and 
that embracing plurality, as did the Editor of this Journal 
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when he accepted our work, may be the best option, to 
the benefit of patients, donors and the wider community. 
The Authors declare no conflicts of interest.
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